Global Clinical Biomarkers Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Clinical Biomarkers
    1.2 Classification of Clinical Biomarkers by Type
        1.2.1 Overview: Global Clinical Biomarkers Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Clinical Biomarkers Revenue Market Share by Type in 2020
        1.2.3 Diagnostic Biomarkers
        1.2.4 Predictive Biomarkers
        1.2.5 Prognostic Biomarkers
    1.3 Global Clinical Biomarkers Market by Application
        1.3.1 Overview: Global Clinical Biomarkers Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Research and Academic Laboratories
        1.3.3 Biopharmaceutical and Biotech Companies
        1.3.4 Diagnostic Centers
        1.3.5 Others
    1.4 Global Clinical Biomarkers Market Size & Forecast
    1.5 Global Clinical Biomarkers Market Size and Forecast by Region
        1.5.1 Global Clinical Biomarkers Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Clinical Biomarkers Market Size by Region, (2016-2021)
        1.5.3 North America Clinical Biomarkers Market Size and Prospect (2016-2026)
        1.5.4 Europe Clinical Biomarkers Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Clinical Biomarkers Market Size and Prospect (2016-2026)
        1.5.6 South America Clinical Biomarkers Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Clinical Biomarkers Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Clinical Biomarkers Market Drivers
        1.6.2 Clinical Biomarkers Market Restraints
        1.6.3 Clinical Biomarkers Trends Analysis
2 Company Profiles
    2.1 Abbott Laboratories
        2.1.1 Abbott Laboratories Details
        2.1.2 Abbott Laboratories Major Business
        2.1.3 Abbott Laboratories Clinical Biomarkers Product and Solutions
        2.1.4 Abbott Laboratories Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Abbott Laboratories Recent Developments and Future Plans
    2.2 Agilent Technologies, Inc.
        2.2.1 Agilent Technologies, Inc. Details
        2.2.2 Agilent Technologies, Inc. Major Business
        2.2.3 Agilent Technologies, Inc. Clinical Biomarkers Product and Solutions
        2.2.4 Agilent Technologies, Inc. Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Agilent Technologies, Inc. Recent Developments and Future Plans
    2.3 ALCEDIAG
        2.3.1 ALCEDIAG Details
        2.3.2 ALCEDIAG Major Business
        2.3.3 ALCEDIAG Clinical Biomarkers Product and Solutions
        2.3.4 ALCEDIAG Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 ALCEDIAG Recent Developments and Future Plans
    2.4 Becton, Dickinson and Company
        2.4.1 Becton, Dickinson and Company Details
        2.4.2 Becton, Dickinson and Company Major Business
        2.4.3 Becton, Dickinson and Company Clinical Biomarkers Product and Solutions
        2.4.4 Becton, Dickinson and Company Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Becton, Dickinson and Company Recent Developments and Future Plans
    2.5 bioMérieux S.A.
        2.5.1 bioMérieux S.A. Details
        2.5.2 bioMérieux S.A. Major Business
        2.5.3 bioMérieux S.A. Clinical Biomarkers Product and Solutions
        2.5.4 bioMérieux S.A. Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 bioMérieux S.A. Recent Developments and Future Plans
    2.6 Bio-Rad Laboratories, Inc.
        2.6.1 Bio-Rad Laboratories, Inc. Details
        2.6.2 Bio-Rad Laboratories, Inc. Major Business
        2.6.3 Bio-Rad Laboratories, Inc. Clinical Biomarkers Product and Solutions
        2.6.4 Bio-Rad Laboratories, Inc. Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
    2.7 CENTOGENE N.V.
        2.7.1 CENTOGENE N.V. Details
        2.7.2 CENTOGENE N.V. Major Business
        2.7.3 CENTOGENE N.V. Clinical Biomarkers Product and Solutions
        2.7.4 CENTOGENE N.V. Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 CENTOGENE N.V. Recent Developments and Future Plans
    2.8 F. Hoffmann-La Roche Ltd.
        2.8.1 F. Hoffmann-La Roche Ltd. Details
        2.8.2 F. Hoffmann-La Roche Ltd. Major Business
        2.8.3 F. Hoffmann-La Roche Ltd. Clinical Biomarkers Product and Solutions
        2.8.4 F. Hoffmann-La Roche Ltd. Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
    2.9 Enzo Biochem Inc.
        2.9.1 Enzo Biochem Inc. Details
        2.9.2 Enzo Biochem Inc. Major Business
        2.9.3 Enzo Biochem Inc. Clinical Biomarkers Product and Solutions
        2.9.4 Enzo Biochem Inc. Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Enzo Biochem Inc. Recent Developments and Future Plans
    2.10 Illumina, Inc. 
        2.10.1 Illumina, Inc. Details
        2.10.2 Illumina, Inc. Major Business
        2.10.3 Illumina, Inc. Clinical Biomarkers Product and Solutions
        2.10.4 Illumina, Inc. Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Illumina, Inc. Recent Developments and Future Plans
    2.11 Myriad Genetics, Inc.
        2.11.1 Myriad Genetics, Inc. Details
        2.11.2 Myriad Genetics, Inc. Major Business
        2.11.3 Myriad Genetics, Inc. Clinical Biomarkers Product and Solutions
        2.11.4 Myriad Genetics, Inc. Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Myriad Genetics, Inc. Recent Developments and Future Plans
    2.12 Quest Diagnostics Incorporated
        2.12.1 Quest Diagnostics Incorporated Details
        2.12.2 Quest Diagnostics Incorporated Major Business
        2.12.3 Quest Diagnostics Incorporated Clinical Biomarkers Product and Solutions
        2.12.4 Quest Diagnostics Incorporated Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
    2.13 QIAGEN N.V.
        2.13.1 QIAGEN N.V. Details
        2.13.2 QIAGEN N.V. Major Business
        2.13.3 QIAGEN N.V. Clinical Biomarkers Product and Solutions
        2.13.4 QIAGEN N.V. Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 QIAGEN N.V. Recent Developments and Future Plans
    2.14 Thermo Fisher Scientific Inc.
        2.14.1 Thermo Fisher Scientific Inc. Details
        2.14.2 Thermo Fisher Scientific Inc. Major Business
        2.14.3 Thermo Fisher Scientific Inc. Clinical Biomarkers Product and Solutions
        2.14.4 Thermo Fisher Scientific Inc. Clinical Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Clinical Biomarkers Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Clinical Biomarkers Players Market Share
        3.2.2 Top 10 Clinical Biomarkers Players Market Share
        3.2.3 Market Competition Trend
    3.3 Clinical Biomarkers Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Clinical Biomarkers Revenue and Market Share by Type (2016-2021)
    4.2 Global Clinical Biomarkers Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Clinical Biomarkers Revenue Market Share by Application (2016-2021)
    5.2 Clinical Biomarkers Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Clinical Biomarkers Revenue by Type (2016-2026)
    6.2 North America Clinical Biomarkers Revenue by Application (2016-2026)
    6.3 North America Clinical Biomarkers Market Size by Country
        6.3.1 North America Clinical Biomarkers Revenue by Country (2016-2026)
        6.3.2 United States Clinical Biomarkers Market Size and Forecast (2016-2026)
        6.3.3 Canada Clinical Biomarkers Market Size and Forecast (2016-2026)
        6.3.4 Mexico Clinical Biomarkers Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Clinical Biomarkers Revenue by Type (2016-2026)
    7.2 Europe Clinical Biomarkers Revenue by Application (2016-2026)
    7.3 Europe Clinical Biomarkers Market Size by Country
        7.3.1 Europe Clinical Biomarkers Revenue by Country (2016-2026)
        7.3.2 Germany Clinical Biomarkers Market Size and Forecast (2016-2026)
        7.3.3 France Clinical Biomarkers Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Clinical Biomarkers Market Size and Forecast (2016-2026)
        7.3.5 Russia Clinical Biomarkers Market Size and Forecast (2016-2026)
        7.3.6 Italy Clinical Biomarkers Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Clinical Biomarkers Revenue by Type (2016-2026)
    8.2 Asia-Pacific Clinical Biomarkers Revenue by Application (2016-2026)
    8.3 Asia-Pacific Clinical Biomarkers Market Size by Region
        8.3.1 Asia-Pacific Clinical Biomarkers Revenue by Region (2016-2026)
        8.3.2 China Clinical Biomarkers Market Size and Forecast (2016-2026)
        8.3.3 Japan Clinical Biomarkers Market Size and Forecast (2016-2026)
        8.3.4 South Korea Clinical Biomarkers Market Size and Forecast (2016-2026)
        8.3.5 India Clinical Biomarkers Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Clinical Biomarkers Market Size and Forecast (2016-2026)
        8.3.7 Australia Clinical Biomarkers Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Clinical Biomarkers Revenue by Type (2016-2026)
    9.2 South America Clinical Biomarkers Revenue by Application (2016-2026)
    9.3 South America Clinical Biomarkers Market Size by Country
        9.3.1 South America Clinical Biomarkers Revenue by Country (2016-2026)
        9.3.2 Brazil Clinical Biomarkers Market Size and Forecast (2016-2026)
        9.3.3 Argentina Clinical Biomarkers Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Clinical Biomarkers Revenue by Type (2016-2026)
    10.2 Middle East & Africa Clinical Biomarkers Revenue by Application (2016-2026)
    10.3 Middle East & Africa Clinical Biomarkers Market Size by Country
        10.3.1 Middle East & Africa Clinical Biomarkers Revenue by Country (2016-2026)
        10.3.2 Turkey Clinical Biomarkers Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Clinical Biomarkers Market Size and Forecast (2016-2026)
        10.3.4 UAE Clinical Biomarkers Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer